S&P 500   3,106.70 (-0.43%)
DOW   27,799.95 (-0.48%)
QQQ   201.84 (-0.75%)
CGC   18.11 (+18.21%)
BABA   182.49 (-1.49%)
T   36.90 (-2.90%)
ACB   2.66 (+13.22%)
F   8.72 (-2.02%)
BAC   32.63 (-0.94%)
DIS   146.54 (-1.24%)
S&P 500   3,106.70 (-0.43%)
DOW   27,799.95 (-0.48%)
QQQ   201.84 (-0.75%)
CGC   18.11 (+18.21%)
BABA   182.49 (-1.49%)
T   36.90 (-2.90%)
ACB   2.66 (+13.22%)
F   8.72 (-2.02%)
BAC   32.63 (-0.94%)
DIS   146.54 (-1.24%)
S&P 500   3,106.70 (-0.43%)
DOW   27,799.95 (-0.48%)
QQQ   201.84 (-0.75%)
CGC   18.11 (+18.21%)
BABA   182.49 (-1.49%)
T   36.90 (-2.90%)
ACB   2.66 (+13.22%)
F   8.72 (-2.02%)
BAC   32.63 (-0.94%)
DIS   146.54 (-1.24%)
S&P 500   3,106.70 (-0.43%)
DOW   27,799.95 (-0.48%)
QQQ   201.84 (-0.75%)
CGC   18.11 (+18.21%)
BABA   182.49 (-1.49%)
T   36.90 (-2.90%)
ACB   2.66 (+13.22%)
F   8.72 (-2.02%)
BAC   32.63 (-0.94%)
DIS   146.54 (-1.24%)
Log in

Adamas Pharmaceuticals News Headlines (NASDAQ:ADMS)

$5.36
-0.08 (-1.47 %)
(As of 11/20/2019 02:44 PM ET)
Today's Range
$5.34
Now: $5.36
$5.61
50-Day Range
$3.46
MA: $4.38
$5.63
52-Week Range
$3.35
Now: $5.36
$12.57
Volume14,034 shs
Average Volume353,170 shs
Market Capitalization$149.33 million
P/E RatioN/A
Dividend YieldN/A
Beta1.61

Headlines

Adamas Pharmaceuticals (NASDAQ ADMS) News Headlines

Source:
DateHeadline
Edited Transcript of ADMS earnings conference call or presentation 7-Nov-19 9:30pm GMTEdited Transcript of ADMS earnings conference call or presentation 7-Nov-19 9:30pm GMT
finance.yahoo.com - November 19 at 9:01 AM
Critical Analysis: Adial Pharmaceuticals (NASDAQ:ADIL) & Adamas Pharmaceuticals (NASDAQ:ADMS)Critical Analysis: Adial Pharmaceuticals (NASDAQ:ADIL) & Adamas Pharmaceuticals (NASDAQ:ADMS)
www.americanbankingnews.com - November 18 at 9:36 PM
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Short Interest UpdateAdamas Pharmaceuticals Inc (NASDAQ:ADMS) Short Interest Update
www.americanbankingnews.com - November 14 at 3:50 AM
Short Interest in Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Expands By 64.7%Short Interest in Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Expands By 64.7%
www.americanbankingnews.com - November 11 at 4:41 PM
Research Analysts Issue Forecasts for Adamas Pharmaceuticals Incs Q1 2021 Earnings (NASDAQ:ADMS)Research Analysts Issue Forecasts for Adamas Pharmaceuticals Inc's Q1 2021 Earnings (NASDAQ:ADMS)
www.americanbankingnews.com - November 11 at 2:37 PM
Adamas Pharmaceuticals (NASDAQ:ADMS) Issues  Earnings ResultsAdamas Pharmaceuticals (NASDAQ:ADMS) Issues Earnings Results
www.americanbankingnews.com - November 9 at 1:39 PM
Adamas Pharmaceuticals (NASDAQ:ADMS) PT Lowered to $16.00 at JMP SecuritiesAdamas Pharmaceuticals (NASDAQ:ADMS) PT Lowered to $16.00 at JMP Securities
www.americanbankingnews.com - November 8 at 4:39 PM
Adamas Pharmaceuticals (ADMS) "Hold" Rating Reaffirmed at Needham & Company LLCAdamas Pharmaceuticals' (ADMS) "Hold" Rating Reaffirmed at Needham & Company LLC
www.americanbankingnews.com - November 8 at 1:01 PM
Adamas Pharmaceuticals (NASDAQ:ADMS) Stock Rating Reaffirmed by Northland SecuritiesAdamas Pharmaceuticals (NASDAQ:ADMS) Stock Rating Reaffirmed by Northland Securities
www.americanbankingnews.com - November 8 at 9:43 AM
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 2019 Results - Earnings Call TranscriptAdamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 12:20 AM
Adamas Pharmaceuticals (ADMS) Reports Q3 Loss, Lags Revenue EstimatesAdamas Pharmaceuticals (ADMS) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 8 at 12:20 AM
Adamas Reports Third Quarter 2019 Financial ResultsAdamas Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 7 at 7:20 PM
What's in the Offing for Humana's (HUM) Earnings in Q3?What's in the Offing for Humana's (HUM) Earnings in Q3?
finance.yahoo.com - November 4 at 12:43 PM
 Brokerages Anticipate Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Will Announce Quarterly Sales of $14.36 Million Brokerages Anticipate Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Will Announce Quarterly Sales of $14.36 Million
www.americanbankingnews.com - November 3 at 5:16 AM
Adamas Pharmaceuticals (ADMS) Set to Announce Earnings on ThursdayAdamas Pharmaceuticals (ADMS) Set to Announce Earnings on Thursday
www.americanbankingnews.com - November 1 at 12:02 PM
Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Receives Consensus Recommendation of "Hold" from AnalystsAdamas Pharmaceuticals Inc (NASDAQ:ADMS) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 1 at 11:02 AM
Zacks: Analysts Anticipate Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Will Announce Earnings of -$0.90 Per ShareZacks: Analysts Anticipate Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Will Announce Earnings of -$0.90 Per Share
www.americanbankingnews.com - November 1 at 6:24 AM
Adamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseAdamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
finance.yahoo.com - October 31 at 12:07 PM
Adamas Pharmaceuticals, Inc. Common Stock (ADMS) Short InterestAdamas Pharmaceuticals, Inc. Common Stock (ADMS) Short Interest
www.nasdaq.com - October 28 at 7:12 PM
Adamas Pharmaceuticals, Inc. Common Stock (ADMS) Advanced ChartingAdamas Pharmaceuticals, Inc. Common Stock (ADMS) Advanced Charting
www.nasdaq.com - October 28 at 7:12 PM
Can We See Significant Institutional Ownership On The Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Share Register?Can We See Significant Institutional Ownership On The Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Share Register?
finance.yahoo.com - October 28 at 9:12 AM
Adamas to Present at Upcoming Cantor Fitzgerald Investor ConferenceAdamas to Present at Upcoming Cantor Fitzgerald Investor Conference
finance.yahoo.com - September 27 at 4:40 PM
Adamas Announces New Safety and Efficacy Data for GOCOVRI® in Parkinson’s Disease Patients with Dyskinesia at the Movement Disorder Society 2019 International CongressAdamas Announces New Safety and Efficacy Data for GOCOVRI® in Parkinson’s Disease Patients with Dyskinesia at the Movement Disorder Society 2019 International Congress
finance.yahoo.com - September 20 at 1:01 PM
Adamas Announces New Employment Inducement GrantAdamas Announces New Employment Inducement Grant
finance.yahoo.com - September 17 at 4:28 PM
BRIEF-Adamas Pharmaceuticals Appoints Neil Mcfarlane As Chief Executive OfficerBRIEF-Adamas Pharmaceuticals Appoints Neil Mcfarlane As Chief Executive Officer
www.msn.com - September 13 at 8:22 PM
New chief at Adamas PharmaNew chief at Adamas Pharma
seekingalpha.com - September 13 at 3:21 PM
New CEO at Adamas PharmaNew CEO at Adamas Pharma
seekingalpha.com - September 13 at 3:21 PM
Adamas Pharmaceuticals Appoints Neil McFarlane as Chief Executive OfficerAdamas Pharmaceuticals Appoints Neil McFarlane as Chief Executive Officer
finance.yahoo.com - September 13 at 3:21 PM
Easy Come, Easy Go: How Adamas Pharmaceuticals (NASDAQ:ADMS) Shareholders Got Unlucky And Saw 71% Of Their Cash EvaporateEasy Come, Easy Go: How Adamas Pharmaceuticals (NASDAQ:ADMS) Shareholders Got Unlucky And Saw 71% Of Their Cash Evaporate
finance.yahoo.com - September 13 at 3:21 PM
Adamas Pharmaceuticals: A Second Inning In PlayAdamas Pharmaceuticals: A Second Inning In Play
seekingalpha.com - August 26 at 5:48 PM
Adamas Pharmaceuticals Inc (ADMS) Q2 2019 Earnings Call TranscriptAdamas Pharmaceuticals Inc (ADMS) Q2 2019 Earnings Call Transcript
www.fool.com - August 12 at 3:35 AM
Adamas Pharmaceuticals, Inc. Common Stock Historical Stock PricesAdamas Pharmaceuticals, Inc. Common Stock Historical Stock Prices
www.nasdaq.com - August 9 at 5:52 PM
Edited Transcript of ADMS earnings conference call or presentation 8-Aug-19 8:30pm GMTEdited Transcript of ADMS earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 9 at 5:52 PM
Adamas Pharmaceuticals, Inc. (ADMS) CEO Gregory Went on Q2 2019 Results - Earnings Call TranscriptAdamas Pharmaceuticals, Inc. (ADMS) CEO Gregory Went on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 5:11 AM
Need To Know: Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Insiders Have Been Selling SharesNeed To Know: Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Insiders Have Been Selling Shares
finance.yahoo.com - August 9 at 5:11 AM
Adamas Reports Second Quarter 2019 Financial ResultsAdamas Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 9 at 5:11 AM
Adamas Pharmaceuticals (ADMS) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseAdamas Pharmaceuticals (ADMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
www.nasdaq.com - August 1 at 10:54 PM
Adamas Pharmaceuticals (ADMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseAdamas Pharmaceuticals (ADMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - August 1 at 5:53 PM
What's in Store for DENTSPLY SIRONA (XRAY) in Q2 Earnings?What's in Store for DENTSPLY SIRONA (XRAY) in Q2 Earnings?
finance.yahoo.com - July 29 at 5:40 PM
Adamas to Announce Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019Adamas to Announce Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
finance.yahoo.com - July 23 at 5:34 PM
Top Ranked Momentum Stocks to Buy for July 8thTop Ranked Momentum Stocks to Buy for July 8th
finance.yahoo.com - July 8 at 5:25 PM
Bausch Gains 38.9% YTD on Product Launches & Debt ReductionBausch Gains 38.9% YTD on Product Launches & Debt Reduction
finance.yahoo.com - July 5 at 9:33 AM
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the FirmINVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - June 29 at 9:14 AM
Hedge Funds Are Dumping Adamas Pharmaceuticals Inc (ADMS)Hedge Funds Are Dumping Adamas Pharmaceuticals Inc (ADMS)
finance.yahoo.com - June 29 at 9:14 AM
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the FirmIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Adamas Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - June 27 at 9:37 AM
Adamas Pharmaceuticals, Inc. Institutional OwnershipAdamas Pharmaceuticals, Inc. Institutional Ownership
www.nasdaq.com - June 26 at 5:34 PM
Will Adamas Pharmaceuticals Continue to Surge Higher?Will Adamas Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - June 25 at 9:28 AM
Should You Worry About Adamas Pharmaceuticals, Inc.'s (NASDAQ:ADMS) CEO Salary Level?Should You Worry About Adamas Pharmaceuticals, Inc.'s (NASDAQ:ADMS) CEO Salary Level?
finance.yahoo.com - June 20 at 5:39 PM
Adamas +4.7% on Stonepine stakeAdamas +4.7% on Stonepine stake
seekingalpha.com - June 19 at 5:28 PM
Adamas Announces Publication and Presentation of a Data Analysis Demonstrating GOCOVRI Reduces BothAdamas Announces Publication and Presentation of a Data Analysis Demonstrating GOCOVRI Reduces Both
www.nasdaq.com - June 18 at 6:52 PM
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Featured Article: Convertible Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel